These ASX 200 shares could rise 20% to 55%

Brokers have good things to say about these shares.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you on the lookout for some big returns for your investment portfolio? If you are, then it could be worth looking at the ASX 200 shares in this article.

Not only have they recently been named as buys, but they have been tipped to rise 20% or more over the next 12 months.

Here's what analysts are recommending to their clients right now:

Smiling couple sitting on a couch with laptops fist pump each other.

Image source: Getty Images

Boss Energy Ltd (ASX: BOE)

This ASX uranium stock could be undervalued according to analysts at Bell Potter. Last week, the broker put a buy rating and $1.95 price target on its shares. Based on its current share price of $1.58, this implies potential upside of 23% for investors between now and this time next year.

Bell Potter highlights that this recommendation is based on the Honeymoon project operating with higher costs and production limitations. This could change for the better, pending its project review. It said:

We lower our TP to $1.95/sh (previously $2.00/sh) and maintain our Buy recommendation. Our valuation assumes production at Honeymoon over the short 10Y mine life is limited to ~1.6Mlbs pa and costs remain elevated, until such a time that management have completed the work to guide otherwise. NPAT changes are: FY26 -24%, FY27 -25% and FY28 -2%.

Nextdc Ltd (ASX: NXT)

Over at Ord Minnett, its analysts think this data centre operator's shares are dirt cheap. Especially given recent contract wins, which it feels bode well for its FY 2026 results.

The broker has put a buy rating and $20.50 price target on the ASX 200 share. Based on its current share price of $13.00, this implies potential upside of over 55% for investors over the next 12 months.

Commenting on its buy recommendation, Ord Minnett said:

NextDC (NXT) announced that contract wins had boosted contracted utilisation of its centres to 316 megawatts (MW), up 71MW, or 29%, since 30 June. Ord Minnett notes NextDC had only guided to 50–100MW of contract wins for FY26, so the latest announcement, along with industry feedback highlighting strong demand from both western and eastern hyperscalers, bodes well for the full-year outcome.

We have raised our target price on NextDC to $20.50 from $19.00 to incorporate our assumed value of the agreement with Open AI, although we have not yet changed our earnings estimates due to the lack of detail and operational timelines. We reiterate our Buy recommendation.

Motley Fool contributor James Mickleboro has positions in Nextdc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Magellan and Ramsay Health Care shares

A leading expert forecasts growing headwinds for Magellan and Ramsay Health Care shares. But why?

Read more »

Pilot on the phone looking distraught.
Broker Notes

Sell alert! Why this expert is ditching Qantas shares for this ASX 200 defence stock

A leading expert is selling Qantas shares and buying this surging ASX 200 defence stock instead. But why?

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

Up 64%, 3 reasons this expert predicts Pro Medicus shares will keep on giving

A leading expert forecasts more outperformance from the surging Pro Medicus share price.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

A scientist in a white coat and glasses puts her arms in the air in a sign of strength and success.
Broker Notes

Morgans tips a 600%+ return for this ASX biotech stock

Good clinical study progress has the broker bullish on this company.

Read more »

Wlorker on a laptop on top of solar panels.
Broker Notes

Up 8%, should I buy the rebound in Origin Energy shares today?

A leading analyst provides his forecast for Origin Energy’s rebounding shares.

Read more »

A woman stands in a field and raises her arms to welcome a golden sunset.
Gold

4 ASX 200 gold shares to buy: Experts

Experts explain their buy ratings following these miners' June quarter reports.

Read more »

Three balls at various places on a cycle.
Broker Notes

6 ASX uranium shares to buy ahead of yellow cake rising to US$200 per pound: experts

This broker tips 83% to 295% upside over 12 months for its 6 top ASX uranium share picks.

Read more »